Negative regulation of MAPK pathway
REACTOME PATHWAYThe Negative regulation of MAPK pathway pathway (Reactome ID: R-HSA-5675221) involves 15 genes and is affected by 33 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Negative regulation of MAPK pathway
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Sorafenib | — | 300 |
| 2 | Vemurafenib | — | 298 |
| 3 | pd98059 | — | 7 |
| 4 | trametinib | — | 296 |
| 5 | Dasatinib | — | 299 |
| 6 | alsterpaullone | — | 12 |
| 7 | kenpaullone | — | 8 |
| 8 | sp600125 | — | 117 |
| 9 | isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from | — | 300 |
| 10 | withaferin | — | 300 |
| 11 | plumbagin [Supplementary Concept] | — | 300 |
| 12 | Axitinib | — | 298 |
| 13 | Quercetin | — | 300 |
| 14 | Okadaic Acid | — | 300 |
| 15 | tyrphostin ag 1478 | — | 4 |
| 16 | Clotrimazole | — | 296 |
| 17 | fisetin | — | 78 |
| 18 | Progesterone | — | 299 |
| 19 | 2-Chloroadenosine 2-Chloroadenosine. | — | 300 |
| 20 | Benzalkonium Compounds | — | 299 |
| 21 | Calcimycin | — | 216 |
| 22 | daph | — | 2 |
| 23 | Diphenhydramine | — | 14 |
| 24 | ha1004 | — | 4 |
| 25 | Lithocholic Acid | — | 300 |
| 26 | Loratadine | — | 296 |
| 27 | trequinsin hydrochloride | — | 1 |
| 28 | arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside) [Supplementary Concept] isolated from | — | 300 |
| 29 | myricetin-3-O-galactopyranoside [Supplementary Concept] | — | 300 |
| 30 | Anisomycin | — | 247 |
| 31 | ninhydrin | — | 300 |
| 32 | Suramin | — | 300 |
| 33 | Tetracycline | — | 300 |
About the Negative regulation of MAPK pathway Pathway
The Negative regulation of MAPK pathway pathway is catalogued in Reactome (ID: R-HSA-5675221) and involves 15 genes. In the BiohacksAI corpus, 33 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ARAF, BRAF, DUSP5, MAP2K1, MAP2K2.